About the webinar

Vaccine trials are among the most difficult clinical trials due to their larger target populations and the resultant study sizes in Phase III trials.

The unique considerations of vaccine trials has led to the development of domain specific terminology, methods and tools.

However, the race for Covid-19 vaccines has led to a number of interesting evolutions and adaptations that successfully accelerated the development and evaluation of these vital vaccines.

In this webinar, we will explore the characteristics of vaccines trials, review recent Covid-19 trials while evaluating the impact of group sequential design on the early assessment of these vaccines